Brief: Vicore Pharma To Carry Out Directed Issue

Vicore Pharma Holding AB

13/11/2019 08:24

Nov 13 (Reuters) - Vicore Pharma Holding AB  VICOR.ST :
    * SAID ON TUESDAY INTENDS TO CARRY OUT A DIRECTED SHARE
ISSUE
    * INTENDS TO EXECUTE A DIRECTED SHARE ISSUE OF APPROXIMATELY
7
MILLION SHARES TO INSTITUTIONAL INVESTORS
    * HEALTHCAP VII L.P., REPRESENTING APPROXIMATELY 27.8
PERCENT OF
THE TOTAL NUMBER OF SHARES IN CO, HAS EXPRESSED ITS INTENTION TO
SUBSCRIBE FOR ITS PRO RATA SHARE OF THE ISSUE
    * INTENDS TO USE POTENTIAL PROCEEDS TO FINANCE CO'S
CONTINUED
DEVELOPMENT OF DRUG DEVELOPMENT PROGRAM VP01 INCLUDING AN
OPEN-LABEL EXTENSION STUDY IN CONNECTION WITH THE PLANNED PHASE
II STUDY IN IDIOPATHIC PULMONARY FIBROSIS (IPF), C'S CONTINUED
DEVELOPMENT OF THE DRUG DEVELOPMENT PROGRAM VP02 THROUGH A PHASE
IB STUDY, AND GENERAL CORPORATE PURPOSES

    
 Source text for Eikon:  urn:newsml:reuters.com:*:nWkr8XZzNL
    
 Further company coverage:  VICOR.ST  
   


 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10))